These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36188226)

  • 1. Prognostic and immunotherapeutic significance of mannose receptor C type II in 33 cancers: An integrated analysis.
    Zhao Z; Yang Y; Liu Z; Chen H; Guan X; Jiang Z; Yang M; Liu H; Chen T; Gao Y; Zou S; Wang X
    Front Mol Biosci; 2022; 9():951636. PubMed ID: 36188226
    [No Abstract]   [Full Text] [Related]  

  • 2. A Comprehensive Pan-Cancer Analysis of 33 Human Cancers Reveals the Immunotherapeutic Value of Aryl Hydrocarbon Receptor.
    Mo Z; Li P; Cao Z; Zhang S
    Front Immunol; 2021; 12():564948. PubMed ID: 34290693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive pan-cancer analysis of 33 human cancers reveals immunotherapeutic value of focal adhesion tyrosine kinase.
    Shi Y; Ju M; Zhang Y; Liang L; Sun X; Di X
    Medicine (Baltimore); 2024 Mar; 103(12):e37362. PubMed ID: 38518034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker.
    Xu Y; Lin Z; Ji Y; Zhang C; Tang X; Li C; Liu T
    Eur J Med Res; 2023 Oct; 28(1):438. PubMed ID: 37848933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory response signature score model for predicting immunotherapy response and pan-cancer prognosis.
    Chen S; Huang M; Zhang L; Huang Q; Wang Y; Liang Y
    Comput Struct Biotechnol J; 2024 Dec; 23():369-383. PubMed ID: 38226313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data.
    Shen C; Fu C; Suo Y; Li K; Zhang Z; Yang S; Zhang Y; Lin Y; Li Z; Wu Z; Huang S; Chen H; Fan Z; Hu H
    Heliyon; 2023 Jun; 9(6):e16897. PubMed ID: 37346342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis.
    Ye Y; Jiang H; Wu Y; Wang G; Huang Y; Sun W; Zhang M
    Front Mol Biosci; 2022; 9():1001225. PubMed ID: 36213111
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular Characterization Clinical and Immunotherapeutic Characteristics of m5C Regulator NOP2 Across 33 Cancer Types.
    Liu T; Zhang J; Lin C; Liu G; Xie G; Dai Z; Yu P; Wang J; Guo L
    Front Cell Dev Biol; 2022; 10():839136. PubMed ID: 35372330
    [No Abstract]   [Full Text] [Related]  

  • 10. Pan-cancer analysis of CREB3L1 as biomarker in the prediction of prognosis and immunotherapeutic efficacy.
    Lin Z; Wu Y; Xiao X; Zhang X; Wan J; Zheng T; Chen H; Liu T; Tang X
    Front Genet; 2022; 13():938510. PubMed ID: 36171879
    [No Abstract]   [Full Text] [Related]  

  • 11. Pan-Cancer Analysis Reveals the Multidimensional Expression and Prognostic and Immunologic Roles of
    Zhang S; Xiong H; Yang J; Yuan X
    Front Mol Biosci; 2021; 8():792154. PubMed ID: 35155565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive pancancer analysis reveals the potential value of RAR-related orphan receptor C (RORC) for cancer immunotherapy.
    He S; Yu J; Sun W; Sun Y; Tang M; Meng B; Liu Y; Li J
    Front Genet; 2022; 13():969476. PubMed ID: 36186454
    [No Abstract]   [Full Text] [Related]  

  • 13. Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction.
    Song J; Yang R; Wei R; Du Y; He P; Liu X
    Mol Med; 2022 May; 28(1):47. PubMed ID: 35508972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and immunological role of Fam20C in pan-cancer.
    Liu X; Zhan Y; Xu W; Liu X; Geng Y; Liu L; Da J; Wang J; Zhang X; Jin H; Liu Z; Guo S; Zhang B; Li Y
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33306121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6AMT1 is a novel potential diagnostic, prognostic and immunotherapy response biomarker in pan-cancer.
    Wang M; Zhu J; Ye Y; Li P; Sun W; Zhang M
    Aging (Albany NY); 2023 Jul; 15(13):6526-6544. PubMed ID: 37437243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapeutic value of NUSAP1 associated with bladder cancer through a comprehensive analysis of 33 human cancer cases.
    Wen X; Hou J; Chu Y; Liao G; Wu G; Fang S; Xiao S; Qiu L; Xiong L
    Am J Cancer Res; 2024; 14(3):959-978. PubMed ID: 38590423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
    Front Immunol; 2021; 12():653836. PubMed ID: 33897701
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
    Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
    Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyroptosis-related prognosis model, immunocyte infiltration characterization, and competing endogenous RNA network of glioblastoma.
    Ding MR; Qu YJ; Peng X; Chen JF; Zhang MX; Zhang T; Hu B; An HM
    BMC Cancer; 2022 Jun; 22(1):611. PubMed ID: 35658846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-cancer analysis reveals interleukin-17 family members as biomarkers in the prediction for immune checkpoint inhibitor curative effect.
    Han X; Ye J; Huang R; Li Y; Liu J; Meng T; Song D
    Front Immunol; 2022; 13():900273. PubMed ID: 36159856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.